New Generic Drug Law

SCOTUS Decision in Pliva v. Mensing Affects 70 Percent of All Drug Prescriptions

Washington, DC—Today’s U.S. Supreme Court decision in Pliva v. Mensing is a disastrous outcome for patient safety, giving generic drug companies legal immunity when they ignore harmful side-effects of the drugs they manufacturer and profit from.  This decision eliminates any incentive for generic manufacturers to ensure their drug is safe and adequately warn consumers of their drugs’ potential dangers.

For the full article see this AAJ announcement with complete drug listing.